Shandong Sinobioway Biomedicine Co Ltd Cash Flow Conversion Efficiency
Shandong Sinobioway Biomedicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) has a cash flow conversion efficiency ratio of -0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-86.58 Million ≈ $-12.67 Million USD) by net assets (CN¥1.99 Billion ≈ $291.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
Cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Sinobioway Biomedicine Co Ltd share price for real-time trading data and today's change.
Shandong Sinobioway Biomedicine Co Ltd Cash Flow Conversion Ratio Explained
Shandong Sinobioway Biomedicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shandong Sinobioway Biomedicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Sinobioway Biomedicine Co Ltd ranked by their cash flow conversion efficiency. Also see Shandong Sinobioway Biomedicine Co Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Assembly Biosciences Inc
NASDAQ:ASMB
|
-0.051x |
|
WA1 Resources Ltd
AU:WA1
|
0.004x |
|
Youngy Health Co Ltd
SHE:300247
|
-0.015x |
|
Bin Chuan Enterprise Co Ltd
TWO:1569
|
-0.024x |
|
NH SPAC 8
KQ:225570
|
-0.014x |
|
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
|
0.027x |
|
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
|
-0.053x |
|
Shanghai Yahong Moulding Co Ltd
SHG:603159
|
0.056x |
Annual Cash Flow Conversion Efficiency for Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. Review Shandong Sinobioway Biomedicine Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.95 Billion ≈ $284.82 Million |
CN¥-253.73 Million ≈ $-37.13 Million |
-0.130x | -3926.70% |
| 2024-12-31 | CN¥2.02 Billion ≈ $295.93 Million |
CN¥-6.55 Million ≈ $-958.04K |
-0.003x | +80.72% |
| 2023-12-31 | CN¥2.17 Billion ≈ $318.08 Million |
CN¥-36.51 Million ≈ $-5.34 Million |
-0.017x | +23.91% |
| 2022-12-31 | CN¥2.47 Billion ≈ $361.21 Million |
CN¥-54.49 Million ≈ $-7.97 Million |
-0.022x | -18.45% |
| 2021-12-31 | CN¥2.47 Billion ≈ $361.34 Million |
CN¥-46.02 Million ≈ $-6.73 Million |
-0.019x | -320.54% |
| 2020-12-31 | CN¥2.19 Billion ≈ $320.56 Million |
CN¥18.51 Million ≈ $2.71 Million |
0.008x | -58.31% |
| 2019-12-31 | CN¥2.39 Billion ≈ $349.56 Million |
CN¥48.41 Million ≈ $7.08 Million |
0.020x | -23.24% |
| 2018-12-31 | CN¥2.82 Billion ≈ $412.66 Million |
CN¥74.46 Million ≈ $10.90 Million |
0.026x | -71.58% |
| 2017-12-31 | CN¥2.92 Billion ≈ $427.04 Million |
CN¥271.11 Million ≈ $39.67 Million |
0.093x | +38.67% |
| 2016-12-31 | CN¥2.53 Billion ≈ $369.84 Million |
CN¥169.32 Million ≈ $24.78 Million |
0.067x | +4.28% |
| 2015-12-31 | CN¥2.14 Billion ≈ $313.71 Million |
CN¥137.73 Million ≈ $20.15 Million |
0.064x | -39.90% |
| 2014-12-31 | CN¥749.40 Million ≈ $109.66 Million |
CN¥80.11 Million ≈ $11.72 Million |
0.107x | -5.07% |
| 2013-12-31 | CN¥738.31 Million ≈ $108.04 Million |
CN¥83.13 Million ≈ $12.16 Million |
0.113x | +25.83% |
| 2012-12-31 | CN¥704.41 Million ≈ $103.08 Million |
CN¥63.04 Million ≈ $9.22 Million |
0.089x | -19.17% |
| 2011-12-31 | CN¥672.28 Million ≈ $98.38 Million |
CN¥74.43 Million ≈ $10.89 Million |
0.111x | -77.09% |
| 2010-12-31 | CN¥177.34 Million ≈ $25.95 Million |
CN¥85.71 Million ≈ $12.54 Million |
0.483x | +15.97% |
| 2009-12-31 | CN¥129.71 Million ≈ $18.98 Million |
CN¥54.06 Million ≈ $7.91 Million |
0.417x | +3.22% |
| 2008-12-31 | CN¥116.12 Million ≈ $16.99 Million |
CN¥46.89 Million ≈ $6.86 Million |
0.404x | +35.21% |
| 2007-12-31 | CN¥83.94 Million ≈ $12.28 Million |
CN¥25.07 Million ≈ $3.67 Million |
0.299x | -- |
About Shandong Sinobioway Biomedicine Co Ltd
Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Y… Read more